Clearbridge Health

Clearbridge Health Financial Leverage

The Financial Leverage (Equity Multiplier) of Clearbridge Health (1H3.SI) as of Oct 8, 2026 is 2.85. In the previous year, Financial Leverage (Equity Multiplier) was 2.30 — a change of 23.95% (higher).

Financial Leverage

2.85

YoY

23.95%

Last updated:

Financial Leverage (Equity Multiplier) of Clearbridge Health is 2025 2.85 . Financial Leverage (Equity Multiplier) of Clearbridge Health was 2024 2.30 . It decreases by 23.95% higher compared to the previous year.

The Clearbridge Health Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.32 SGD
Jan 1, 2019
1.93 SGD
Jan 1, 2020
1.60 SGD
Jan 1, 2021
1.58 SGD
Jan 1, 2022
1.41 SGD
Jan 1, 2023
2.35 SGD
Jan 1, 2024
2.30 SGD
Jan 1, 2025
2.85 SGD
The Clearbridge Health Financial Leverage history
YEARFinancial LeverageYoY
2.85+23.95%
2.30-1.89%
2.35+67.03%
1.41-11.30%
1.58-0.72%
1.60-17.19%
1.93+46.39%
1.32+16.62%
1.13-6.92%
1.21-1.29%
1.23-48.76%
2.40—
Access this data via the Eulerpool API

Clearbridge Health Stock analysis

What does Clearbridge Health do? Clearbridge Health Ltd is an international company in the healthcare and diagnostics sector based in Singapore. The company was founded in 2017 and focuses on the use of innovative technology, information, and communication systems to provide efficient and precise diagnostics and medical care. The business model of Clearbridge Health is based on a wide range of services and products, divided into three segments: Clinical diagnostics, healthcare services, and digitization. These divisions are interconnected and allow the company to offer a comprehensive range of healthcare services. In the field of clinical diagnostics, the company offers a variety of laboratory and radiology services. Clearbridge Health has a strong presence in Singapore and Indonesia, where it has several diagnostic laboratories specializing in areas such as pathology, microbiology, genetics, and molecular diagnostics. In addition, the company has partnerships with leading diagnostic laboratories worldwide to provide its customers with an even broader range of diagnostic options. In the healthcare services segment, Clearbridge Health offers a wide range of services including diagnosis, treatment, and disease prevention, as well as health management. A key focus in this area is the care of cancer patients. Here, the company has developed a unique self-financing model where it invests in diagnosis and treatment and benefits from the outcomes achieved. The goal is to provide cancer patients with fast diagnosis and comprehensive, personalized treatment. Clearbridge Health has partnerships with leading cancer centers worldwide and utilizes the latest technologies to enable fast and accurate diagnosis. In the digitization segment, Clearbridge Health offers innovative technology solutions to digitalize the healthcare sector and improve efficiency in healthcare delivery. One of the products includes a cloud-based platform for medical imaging called teleradiology. The platform allows for the digital transmission of images from one location to another, saving time and costs and improving efficiency in patient diagnosis and treatment. Clearbridge Health has experienced rapid growth in recent years. The company has expanded its presence in Asia and other parts of the world and continues to pursue an ambitious expansion strategy. The goal is to become a global leader in healthcare and diagnostics. In summary, Clearbridge Health is an innovative company in the healthcare and diagnostics sector that offers a wide range of services and products. The company has a strong presence in Asia and collaborates closely with leading diagnostic laboratories and cancer centers worldwide. Clearbridge Health is committed to improving healthcare delivery and promoting the adoption of innovative technology solutions to enhance efficiency. The company has experienced impressive growth in recent years and continues to pursue an ambitious expansion strategy. Clearbridge Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Clearbridge Health stock

Financial Leverage (Equity Multiplier) of Clearbridge Health is 2.85 in 2025.

Financial Leverage (Equity Multiplier) of Clearbridge Health changed from 2.30 to 2.85, representing a 23.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Clearbridge Health since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Clearbridge Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Clearbridge Health

All Key Metrics — Clearbridge Health